Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New PR on share buyback
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Part of our master agreement with TPL stipulates that they will screen all press releases before submitted by PTSC. Thus the delay and also the lack of information to investors.

"Enlighten me if I am wrong. but I don't believe it makes any sense to link this lack of transparency in this particular case to neither the current litigation in Texas nor the master agreement with TPL". 

That was the whole point in what I was saying.

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply